Inventor · disambiguated record
Vincent Lenaerts
Also filed as: LENAERTS VINCENT
8 granted patents·2 pending applications·362 citations·filing 1993–2005
89Inventor score
Top patents by PatentIndex Score
10 records- 0190US6607748B1Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufactureFiled 2000·Granted Aug 19, 2003·97 cites·43 claims
- 0281US7988998B2Sustained-release tramadol formulations with 24-hour efficacyLABOPHARM INC·Filed 2005·Granted Aug 2, 2011·4 cites·29 claims
- 0381US5603956ACross-linked enzymatically controlled drug releaseLABOPHARM INC·Filed 1994·Granted Feb 18, 1997·70 cites·10 claims
- 0481US5456921AUse of cross-linked amylose as a matrix for the slow release of biologically active compoundsLABOPHARM INC·Filed 1994·Granted Oct 10, 1995·70 cites·29 claims
- 0574US6419957B1Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agentsLABOPHARM INC·Filed 1999·Granted Jul 16, 2002·40 cites·6 claims
- 0674US5616343ACross-linked amylose as a binder/disintegrant in tabletsLABOPHARM INC·Filed 1993·Granted Apr 1, 1997·48 cites·20 claims
- 0768US6284273B1Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compoundsFiled 1998·Granted Sep 4, 2001·33 cites·34 claims
- 0846US2006172006A1Sustained-release tramadol formulations with 24-hour clinical efficacyLENAERTS VINCENT·Filed 2004·Application pending·0 cites
- 0944US2004013726A1Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufactureFiled 2003·Application pending·0 cites
- 1039US8487002B2Controlled-release compositionsLENAERTS VINCENT·Filed 2005·Granted Jul 16, 2013·0 cites·23 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →